- Home
- STEC vs ADIL Comparison
STEC vs ADIL Comparison
Compare STEC & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEC
- ADIL
- Stock Information
- Founded
- STEC 2006
- ADIL 2010
- Country
- STEC China
- ADIL United States
- Employees
- STEC N/A
- ADIL N/A
- Industry
- STEC
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- STEC
- ADIL Health Care
- Exchange
- STEC NYSE
- ADIL Nasdaq
- Market Cap
- STEC 6.3M
- ADIL 6.4M
- IPO Year
- STEC 2021
- ADIL 2018
- Fundamental
- Price
- STEC $1.59
- ADIL $0.97
- Analyst Decision
- STEC
- ADIL
- Analyst Count
- STEC 0
- ADIL 0
- Target Price
- STEC N/A
- ADIL N/A
- AVG Volume (30 Days)
- STEC 4.5M
- ADIL 79.2K
- Earning Date
- STEC 10-29-2024
- ADIL 11-12-2024
- Dividend Yield
- STEC N/A
- ADIL N/A
- EPS Growth
- STEC N/A
- ADIL N/A
- EPS
- STEC N/A
- ADIL N/A
- Revenue
- STEC $260,474,693.00
- ADIL N/A
- Revenue This Year
- STEC $9.76
- ADIL N/A
- Revenue Next Year
- STEC $15.85
- ADIL N/A
- P/E Ratio
- STEC N/A
- ADIL N/A
- Revenue Growth
- STEC N/A
- ADIL N/A
- 52 Week Low
- STEC $0.20
- ADIL $0.77
- 52 Week High
- STEC $7.38
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- STEC 64.50
- ADIL 46.11
- Support Level
- STEC $0.32
- ADIL $0.94
- Resistance Level
- STEC $3.25
- ADIL $1.00
- Average True Range (ATR)
- STEC 0.21
- ADIL 0.04
- MACD
- STEC 0.16
- ADIL 0.00
- Stochastic Oscillator
- STEC 43.38
- ADIL 30.10
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.